Integra LifeSciences

Integra LifeSciences, a leader in medical technology, is dedicated to limiting uncertainty for surgeons, so they can concentrate on providing the best patient care. Integra offers innovative solutions in orthopedic extremity surgery, neurosurgery, spine surgery, and reconstructive and general surgery. Integra's orthopedic products include devices and implants for spine, foot and ankle, hand and wrist, shoulder and elbow, tendon and peripheral nerve protection and repair, and wound repair. Integra is a leader in neurosurgery, offering a broad portfolio of implants, devices, instruments and systems used in neurosurgery, neuromonitoring, neurotrauma, and related critical care. In the United States, Integra is a leading provider of surgical instruments to hospitals, surgery centers and alternate care sites, including physician and dental offices. 
Company Growth (employees)
Type
Public
HQ
Plainsboro Center, US
Size (employees)
3,700 (est)
Integra LifeSciences is headquartered in Plainsboro Center, US

Integra LifeSciences Office Locations

Integra LifeSciences has offices in Plainsboro Center, Oakville, York, Billerica and in 1 other location
Plainsboro Center, US (HQ)
311 Enterprise Dr
Billerica, US
85 Rangeway Rd
West Valley City, US
3498 W 2400 S
York, US
589 Davies Dr
Oakville, CA
2590 Bristol Cir

Integra LifeSciences Financials and Metrics

Integra LifeSciences Financials

Integra LifeSciences's revenue was reported to be $992.1 m in FY, 2016
USD

Revenue (Q3, 2017)

278.8 m

Gross profit (Q3, 2017)

177.1 m

Gross profit margin (Q3, 2017), %

64%

Net income (Q3, 2017)

3.2 m

EBIT (Q3, 2017)

10.6 m

Market capitalization (13-Dec-2017)

4 b

Cash (30-Sep-2017)

481.9 m
Integra LifeSciences's current market capitalization is $4 b.
USDFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

836.2 m928.3 m882.7 m992.1 m

Revenue growth, %

11%(5%)12%

Cost of goods sold

334.1 m352.8 m326.5 m349.1 m

Gross profit

502.1 m575.5 m556.2 m643 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

213.2 m215.1 m231.4 m229.7 m233.7 m244.1 m226.4 m236.8 m249.3 m250.3 m258.6 m282.2 m278.8 m

Cost of goods sold

84.1 m82.4 m87 m86 m86.7 m86.5 m86.1 m84.8 m89.6 m89.3 m86.6 m99 m101.8 m

Gross profit

129.1 m132.7 m144.4 m143.7 m146.9 m157.5 m140.3 m152 m159.7 m161 m172.1 m183.2 m177.1 m

Gross profit Margin, %

61%62%62%63%63%65%62%64%64%64%67%65%64%
USDFY, 2013FY, 2014FY, 2015FY, 2016

Cash

120.6 m72 m48.1 m102.1 m

Inventories

26.8 m29.6 m42.6 m217.3 m

Current Assets

525.2 m529.3 m438.5 m495.2 m

PP&E

200.3 m210 m205.2 m222.4 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

118.9 m129 m137.2 m140.2 m79.9 m131.3 m79.3 m77.1 m86.8 m107.6 m124.1 m154.6 m481.9 m

Inventories

207.4 m215.2 m223.6 m230.5 m233 m241.8 m213.9 m222 m220.4 m219.7 m239.8 m234.7 m232.3 m

Current Assets

510.6 m539.7 m564.2 m562.6 m522 m608.2 m504.9 m494.6 m494 m511.9 m568.9 m616.2 m944.9 m

PP&E

192.7 m205.7 m206.7 m203.9 m210.1 m215.5 m197.2 m210.3 m208.6 m212.2 m229.1 m232.1 m232.2 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(17 m)34 m(3.5 m)74.6 m

Depreciation and Amortization

47 m61.1 m58.9 m72.7 m

Accounts Receivable

(2.9 m)(16 m)(16 m)(17.5 m)

Inventories

(42 m)(27 m)(3.8 m)(9.6 m)
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

(28.6 m)2.2 m4.8 m9.8 m8.4 m5 m(31.9 m)11.6 m12.8 m20.1 m6.4 m
USDY, 2017

Revenue/Employee

75.4 k

Financial Leverage

2.6 x
Show all financial metrics

Integra LifeSciences Market Value History

Integra LifeSciences's Web-traffic and Trends

Integra LifeSciences Online and Social Media Presence

Integra LifeSciences Company Life and Culture

You may also be interested in